J Clin Endocrinol Metab (2003) 88:271925
In the SUSTAIN-6 trial, there was a significantly higher event rate of diabetic retinopathy in the semaglutide-treated group compared with the control (49)
[DOI] [PMC free article] [PubMed] [Google Scholar] 53.Poli V.F.S., Sanches R.B., Moraes A.D.S., Fidalgo J.P.N., Nascimento M.A., Bresciani P., Andrade-Silva S.G., Cipullo M.A.T., Clemente J.C., Caranti D.A
Obesity medications may counter the effects of metabolic adaptation and prevent weight regain
While more research is needed on optimal long-term management strategies, the near-term clinical evidence supporting the type of medically supervised weight loss program Medvi offers is robust and growing
How do GLP-1 injections work for weight loss